Literature DB >> 30383225

High Serum sCD40 and a Distinct Colonic T Cell Profile in Ulcerative Colitis Associated With Primary Sclerosing Cholangitis.

Maria Lampinen1, Johan Vessby1, Annika Fredricsson1, Alkwin Wanders2, Fredrik Rorsman1, Marie Carlson1.   

Abstract

BACKGROUND AND AIMS: There is a strong association between primary sclerosing cholangitis [PSC] and ulcerative colitis [UC], but the immunological link between the two diseases is obscure. We compared serum cytokine profiles of patients with PSC-UC and UC, and investigated a number of selected cytokines in colonic biopsy samples. We also assessed the presence and activation of T cells in peripheral blood and colonic mucosa.
METHODS: Serum samples from 22 patients with PSC-UC, 28 patients with UC, and 19 controls were analysed by a proximity extension assay including 92 inflammatory cytokines. Biopsies from caecum, sigmoid colon, and rectum were collected from the same patients. Quantitative analysis for IFN-γ, IL-2, IL-4, IL-5, IL-13, IL-17A/ E/F, IL-21, IL-22, IL-23, and IL-27 was carried out on tissue homogenates. T cell phenotype was evaluated by flow cytometry.
RESULTS: By multivariate analysis we identified a cluster of serum cytokines with higher levels in PSC-UC, and sCD40 in particular was strongly associated with this patient group. In contrast, colonic cytokines were only modestly increased in PSC-UC, whereas several Th1-, Th2-, and Th17-associated cytokines were increased in UC. Patients with PSC-UC had increased colonic levels of CXCR3-positive CD8+ T cells but fewer CD25-positive CD4+ T cells. An increased CRTH2/CXCR3-quote indicated a predominance of Th-2 type CD4+ T cells in UC patients.
CONCLUSIONS: Our study reveals different cytokine profiles and T cell profiles in PSC-UC and UC, with higher systemic levels of cytokines in PSC-UC, and a more pronounced colonic inflammation in UC. Serum sCD40 could potentially be investigated as a marker for PSC in UC.
Copyright © 2018 European Crohn’s and Colitis Organisation (ECCO). Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Primary sclerosing cholangitis; T cell; cytokine

Mesh:

Substances:

Year:  2019        PMID: 30383225     DOI: 10.1093/ecco-jcc/jjy170

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  4 in total

Review 1.  IL-1 and CD40/CD40L platelet complex: elements of induction of Crohn's disease and new therapeutic targets.

Authors:  Doha Anka Idrissi; Nezha Senhaji; Asmae Aouiss; Loubna Khalki; Youssef Tijani; Nabil Zaid; Fatima Zahra Marhoume; Abdallah Naya; Mounia Oudghiri; Mostafa Kabine; Younes Zaid
Journal:  Arch Pharm Res       Date:  2021-01-04       Impact factor: 4.946

2.  Tissue factor in ulcerative colitis, with and without concomitant primary sclerosing cholangitis.

Authors:  Johan Vessby; Maria Lampinen; Mikael Åberg; Fredrik Rorsman; Agneta Siegbahn; Alkwin Wanders; Marie Carlson
Journal:  Ups J Med Sci       Date:  2019-11-27       Impact factor: 2.384

3.  Discriminant equation using mucosally expressed cytokines and transcription factor for making definite diagnosis of inflammatory bowel disease unclassified.

Authors:  Hiroaki Okuno; Haruei Ogino; Eikichi Ihara; Kei Nishioka; Yoshimasa Tanaka; Takatoshi Chinen; Motoyuki Kohjima; Takamasa Oono; Masatake Tanaka; Takeshi Goya; Nao Fujimori; Yoichiro Iboshi; Takuji Gotoda; Yoshihiro Ogawa
Journal:  BMC Gastroenterol       Date:  2021-02-16       Impact factor: 3.067

4.  AGPAT1 as a Novel Colonic Biomarker for Discriminating Between Ulcerative Colitis With and Without Primary Sclerosing Cholangitis.

Authors:  Johan Vessby; Jacek R Wisniewski; Cecilia Lindskog; Niclas Eriksson; Katja Gabrysch; Katharina Zettl; Alkwin Wanders; Marie Carlson; Fredrik Rorsman; Mikael Åberg
Journal:  Clin Transl Gastroenterol       Date:  2022-05-01       Impact factor: 4.396

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.